PolyNeuroExchange

Your source for expert information on
symptoms, diagnosis, and treatment options
for Peripheral Neuropathies

CIDP Assessment Tools Infographic

Chronic Inflammatory Demyelinating Polyneuropathy (CIDP) Assessment Tools

CIDP

A number of tools are available to assess disease severity and progression in patients with peripheral neuropathies such as CIDP. Gain a better understanding of four of these tools.

Featured Video

View ALL Videos

Overview and Treatment of Guillain-Barr├® Syndrome (GBS)

David R. Cornblath, MD

Johns Hopkins University, Baltimore, MD, USA

7:23 MIN

Learn more about the features, symptoms, diagnosis, and treatment of GBS.

DOWNLOAD PDF

Our Experts

View ALL Experts

Hans D. Katzberg, MD, MSc, FRCP(C)

University Health Network /Toronto General Hospital Canada

Hans D. Katzberg, MD, MSc, FRCP(C)

University Health Network /Toronto General Hospital Canada

Dr. Hans Katzberg is a neuromuscular specialist and clinical investigator at the University Health Network / Toronto General Hospital and has been on faculty at the University of Toronto as Assistant Professor of Neurology.

Michael Lunn, PhD

National Hospital for Neurology and Neurosurgery, Queen Square, London

Michael Lunn, PhD

National Hospital for Neurology and Neurosurgery, Queen Square, London

CIDP

Dr Michael Lunn is a Consultant Neurologist, Clinical Lead in Neuroimmunology and Honorary Senior Lecturer at the National Hospital for Neurology and Neurosurgery.

Vera Bril, BSc, FRCPC, MD

University of Toronto,Toronto, Canada

Vera Bril, BSc, FRCPC, MD

University of Toronto,Toronto, Canada

CIDP

Vera Bril is a Professor of Medicine (Neurology) at the University of Toronto, Director of Neurology at University Health Network and Mount Sinai Hospital and the Krembil Family Chair in Neurology.

Nabil Moumane, MD

Medical Affairs and Pharmacology, CSL Behring

Nabil Moumane, MD

Medical Affairs and Pharmacology, CSL Behring

CIDP
MMN

Nabil Moumane is the Director of Medical Affairs and Pharmacology at CSL Behring.